The race to expand a vaccine opposed to the new coronavirus replaced Tuesday, when pharmaceutical company AstraZeneca suspended global trials of its candidate vaccine, widely recognized as one of the leading applicants for assistance in the COVID-19 pandemic.
AstraZeneca, who developed the vaccine in coordination with Oxford University, announced that he had voluntarily suspended trials so that an independent committee could simply review his knowledge of protection after a trial player had an unforeseen illness.
The announcement has revived global attempts to produce a vaccine opposed to COVID-19, which continues to infect others around the world.
Lately, the World Health Organization has listed 35 candidate vaccines under clinical evaluation, nine of which are in Phase III.
Here is the latest update on the progress of the 10 most sensitive vaccine applicants opposed to coronavirus:
This record photo taken on 21 July 2020 shows an overview of the offices of the British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire. (AFP)
Russian President Vladimir Putin is presiding over an assembly with members of the government through a video liaison at the novo-Ogaryovo State Residence outdoors in Moscow, Russia (Reuters).
A volunteer participates in the Phase III clinical trial of the inactivated Sinopharm CNBG coronavirus vaccine in Abu Dhabi, UAE (Twitter/AShot4Humanity).
U. S. President Donald Trump stops at Fujifilm’s Diosynth Biotechnology Innovation Center, a pharmaceutical production plant where parts for a Candidate Novavax vaccine for possible coronavirus disease (COVID-19) are being developed in Morrrisville, North Carolina, USA. Usa, July 27, 2020. (Reuters)
A researcher works in a laboratory at a Chinese CanSino Biologics vaccine in Tianjin, China, November 20, 2018. Photo taken on November 20, 2018 (Reuters)
Modern Therapeutics noted at COVID-19 in Massachusetts. (Reuters)
Scientists and researchers are working on a possible coronavirus disease vaccine (COVID-19) at Pfizer’s lab in Pearl River, New York, USA. USA, In this photo provided to Reuters on May 5, 2020 (Pfizer / Handout Reuters)
A nurse administers the Chinese vaccine against SinoVac coronavirus to volunteer and physician Ivan Franca at the Emilio Ribas Institute in Sao Paulo, Brazil, 30 July 2020 (Reuters)
Lab technicians talk about coronavirus research, COVID-19, at Janssen Pharmaceutical, a subsidiary of Johnson
The Sanofi logo can be seen at the company’s production center in Vitry-sur-Seine (Reuters).